Facebook Pixel Code

Sun Pharmaceuticals shares gain on US FDA approval of schizophrenia drug

FDA has posted approval for Sun Pharmaceuticals’ generic schizophrenia drug, Risperidone, on its website.

Shares of Sun Pharmaceuticals Industries jumped more than 3% in intra-day trading as the U.S. Food and Drug Administration posted approval for the company’s generic schizophrenia drug on its website.

The company’s Detroit-based subsidiary, Caraco Pharmaceutical Laboratories, won approval for the therapy, generically named risperidone on March 10, according to the USFDA website.

Risperidone is the generic equivalent of Johnson and Johnson’s blockbuster antipsychotic medication, Risperidal, which lost patent protection in 2008.

Shares of the Mumbai-based company were trading up 3.27% at Rs 599.40 at 11:00 am IST on Wednesday on the BSE.

Get live Share Market updates, Stock Market Quotes, and the latest India News and business news on Financial Express. Download the Financial Express App for the latest finance news.

First published on: 12-03-2014 at 12:06 IST
Market Data
Market Data
Today’s Most Popular Stories ×